Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosis

BACKGROUND: MET amplifications occur in human tumors, including non-small cell lung cancer (NSCLC). MET inhibitors have demonstrated some clinical activity in MET amplified NSCLC, presumably with a gene dose effect. However, the definition of MET positivity or MET amplification as a potential oncoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Overbeck, Tobias Raphael, Cron, Dana Alina, Schmitz, Katja, Rittmeyer, Achim, Körber, Wolfgang, Hugo, Sara, Schnalke, Juliane, Lukat, Laura, Hugo, Tabea, Hinterthaner, Marc, Reuter-Jessen, Kirsten, Rosenthal, Tessa, Moecks, Joachim, Bleckmann, Annalen, Schildhaus, Hans-Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354108/
https://www.ncbi.nlm.nih.gov/pubmed/32676323
http://dx.doi.org/10.21037/tlcr-19-339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354108/
https://www.ncbi.nlm.nih.gov/pubmed/32676323
http://dx.doi.org/10.21037/tlcr-19-339

Ejemplares similares